This ongoing qualitative study uses medical (72.4%) and non-medical (27.6%) providers’ narratives to explore barriers and facilitators of buprenorphine – an approved Medication Assisted Treatment (MAT). Please note that the poster presentation represents preliminary findings which may change after data collection is completed.